Genetic Technologies
Personalizing Health

search

  • Home
  • Corporate
  • Medical
    • Overview
    • Breast & Ovarian Cancer
    • Bowel & Uterine Cancer
    • Neurogenetics
    • Epilepsy
  • Forensics
    • Overview
    • Presumptive & Confirmatory Testing
    • Individual DNA Profiling
    • Species Identification
    • Animal Forensic Testing
  • Paternity
    • Legal - Paternity
    • Non Legal - Paternity
    • Legal Practitioners
    • Antenatal
    • Deceased Estate
    • DNA In A Day
    • Sibship
    • Twins
    • Y – Chromosome
    • DNA Profiling
    • Grandparent
    • Immigration
  • Personal
    • Overview
    • Sports Performance
    • Ancestry
  • Animals
    • DNA Testing
    • BITSA
    • Animal Forensics
  • Plants
    • Genomic Services
    • Xpress Sequencing
Announcements


ASX Quarterly Reports - 30 June 2010
ASX Quarterly Reports - 30 June 2010
 
ASX Appendix 3B with covering letter
ASX Appendix 3B with covering letter - 13 July 2010
 
Transfer to NASDAQ Capital Market
Transfer to NASDAQ Capital Market
 
Extension of Quest license
Extension of Quest license
 
Appointment of Lewis Stuart
Appointment of Lewis Stuart
 
Previous Announcements
  • BREVAGen data presented at ASCO 2010
  • Patent claims upheld in full by USPTO
  • EraGen Biosciences License
  • Gen-Probe License
<< Start < Prev 11 12 13 14 15 16 17 18 19 20 Next > End >>

Page 16 of 30
© Genetic Technologies Group 2009 11/09 GTG 08 2371
skynews

Announcements

  • Settlement with GeneSeek
  • Appendix 3B - 20 April 2012
  • Forfeiture of options - 19 April 2012

Latest News

  • GENE: 1H12 Earnings Preview
  • GTG Oct-Dec 2011 4C Commentary
  • Biotech Daily - The Year in Review - CEO Of The Year Dr Paul MacLeman


Share Price

asx_logo_horiz

Share Price: Genetic Technologies